This cohort study examines the possible association of pioglitazone use with the incidence of new bladder cancer in the Kaiser Permanente Northern California Diabetes Registry .
Cohort Study of Pioglitazone and Bladder Cancer in Patients with Diabetes
Investigator: Ferrara, Assiamira
Funder: Takeda Pharmaceuticals North America